Caspase 1 antibody and inflammasome reagents for a pathway that only exists once it fires

Choosing reagents for a pathway that fires

1. Buy against the cleaved form, not the gene. An enzyme that circulates as an inactive precursor is only informative once cleaved. Reagents raised against the neoepitope exposed by cleavage answer the activation question; reagents against the parent detect both forms and are useful only as a loading reference.
2. Read assembly as redistribution, not as amount. Adaptor and sensor proteins signal by forming specks and filaments. Their total abundance may not change at all, so imaging the distribution, or a native gel, tells you what a denaturing blot cannot.
3. Preserve the state at lysis. Proteolysis continues in a lysate and phosphorylation is stripped within minutes. Inhibitors have to be in the buffer before the cells meet it, samples kept cold and processing kept short, or the pathway will look inactive whatever it was doing.
4. Measure the secreted product as well as the cell. Mature cytokines leave the cell, so a lysate blot can miss the output entirely. Pair the cellular readout with a supernatant measurement, and be explicit about which form the assay detects.
5. Control with a stimulus and an inhibitor. A treatment that fires the pathway and one that blocks it bracket every experiment. Without them a band cannot be distinguished from a background, and a negative result cannot be distinguished from a failed stimulation.

The reagent has to match the event

Every step in these pathways is a change of state rather than a change of amount: a cleavage, a phosphorylation, an oligomerisation, a translocation. That makes the choice of reagent unusually consequential, because most catalogue antibodies are raised against the protein rather than against the state.

Read the immunogen and the stated specificity before buying, and where a cleaved form is the question, confirm the supplier shows the cleaved band separately from the precursor.

Handling is the commonest failure

Warm handling, a missing protease inhibitor and a long time between plate and denaturation lose more signal in this area than any reagent choice. The pathway continues to run in the dish while the experiment is being collected.

Fix one lysis protocol for pathway work, make the buffer fresh with inhibitors, date it, and record it with the result. It removes an entire class of irreproducibility.

A tl1a antibody and a cytokine read in two forms

TL1A exists as a membrane protein and as a shed soluble form, and the soluble form is what most assays measure, so a tl1a antibody for a blot is a different purchase from a matched pair for an immunoassay. Expression is low and inducible, which makes an unstimulated negative and a stimulated positive the two lanes that make a band interpretable.

A cxcl12 antibody and a chemokine held on the matrix

Chemokines are secreted and then immobilised on glycosaminoglycans, so a cxcl12 antibody reads a matrix bound gradient in tissue rather than a cytoplasmic pool, and the wash steps decide how much survives. It is small, so transfer is quick and a small pore membrane helps. Its receptor is the usual companion stain, since the pair is what makes a migration argument.

A rankl antibody and the decoy receptor beside it

Bone biology turns on the ratio between RANKL and its decoy receptor rather than on either alone, so a rankl antibody belongs in a figure with the decoy measured on the same samples. The protein is membrane bound and shed, so the form detected has to be stated. A functional readout is osteoclast formation, which no antibody substitutes for.

A ccl2 antibody and a secreted product measured in medium

CCL2 is secreted quickly and accumulates in medium, so a ccl2 antibody reports almost nothing in a cell lysate and the informative sample is conditioned medium with the volume and collection time stated. An immunoassay with a calibration curve is the usual measurement. In tissue the stain is weak and the messenger level is often the better evidence.

A cxcl16 antibody and a chemokine with a membrane form

CXCL16 is unusual in being a transmembrane chemokine that is cleaved to release a soluble ligand, so a cxcl16 antibody has to say whether it detects the membrane form, the shed form or both. Surface staining and a medium measurement are therefore different experiments on the same molecule, and the shedding protease is often the actual subject of the work.

An il22 antibody and a cytokine with a binding protein

IL-22 activity is regulated by a soluble binding protein that competes with its receptor, so a concentration measured by an il22 antibody can overstate what is available, and the honest figure reports the binding protein too. The cytokine is produced by a restricted set of cells, which makes the source the interesting question and an intracellular stain with a stimulation the usual method.

An il-5 antibody and a low abundance cytokine

IL-5 circulates at very low concentrations, so an il-5 antibody is nearly always part of a high sensitivity immunoassay rather than a blot, and the assay's stated lower limit is what decides whether a difference is real. A reading below that limit is not a zero. Intracellular staining after stimulation is how the producing cell population is identified instead.

Common questions

Why does my caspase blot show only the precursor?

Either the pathway did not fire, or the cleaved product left with the supernatant, or the cleavage was reversed during handling. Blot the supernatant as well as the lysate and check the inhibitor cocktail was in the buffer before lysis.

Can abundance report inflammasome activation, or do I need an NLRP3 antibody on assembly?

No. Assembly is the activation event and it does not require new protein. Imaging speck formation, or a native separation, is what reports it; a denaturing blot of total protein does not.

Which controls make these results credible?

A known stimulus, a specific inhibitor, and where possible cells lacking the sensor. Reduction of signal in the knockout is the strongest evidence a reagent is reporting what its label claims.

Browse by service class

• Compare Gene synthesis on advertised prices